beneficial compensatory response to altered systemic metabolic changes in obesity needs further evaluation. Our results also confirm those obtained for skeletal muscle, with reversal of systemic and muscle metabolic derangements only 9 months after BS (3).
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Getting What the Guidelines Stated Matters
We read with interest the recently published report of the multicenter randomized controlled trial (RCT) known as PRECISE-IVUS (plaque regression with cholesterol absorption inhibitor or synthesis inhibitor evaluated by intravascular ultrasound) (1). While we noted that coronary angiographic outcomes in those assigned to combination statin plus ezetemibe therapy compared favorably to those assigned statin monotherapy, we were concerned that the authors did not refer to the 2013 ACC/AHA guidelines in an accurate fashion. Our evidence-based guidelines were not "fire and forget" as the authors write in their discussion. Moreover, they express a serious misconception about what the guidelines actually said about nonstatins.
In both the guideline recommendations tables, key Please note: The authors have reported that they have no relationships relevant to the contents of this paper to disclose. Finally, we would like to thank Drs. Stone,
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